Healthcare Industry News: Posterior Cervical Stabilization
News Release - May 24, 2016
Centinel Spine(TM) Expands STALIF(R) InternationallyNEW YORK, May 24, 2016 -- (Healthcare Sales & Marketing Network) -- Centinel Spine, Inc., (Centinel Spine), the pioneer of Stand-Alone, No-Profile®, Integrated Interbody™ fusion devices, expands its MIDLINE II-Ti product family, a Ti-ACTIVE™ coated, No-Profile, anterior lumbar Integrated Interbody device, in the United States and Australia.
MIDLINE II-Ti, the most recent Centinel Spine innovation for anterior lumbar interbody fusion (ALIF) procedures, represents the sixth generation of STALIF® technology. MIDLINE II-Ti blends the STALIF Integrated Interbody advantage with Ti-ACTIVE, a uniquely texturized, microporous titanium plasma coating, to form a novel technology and approach to ALIF procedures with 8°, 12°, 16° and 20° of lordosis, excellent radiographic visualization and three cancellous screws for optimum stability.
"This expansion is enabling Centinel Spine to rapidly increase market share and represents another key milestone in our Ti-ACTIVE product portfolio," said John J. Viscogliosi, Chairman & CEO, Centinel Spine. "Ti-ACTIVE is the culmination of over 15 years of titanium coating science, engineering and experience. And, as with all Centinel Spine technology, Ti-ACTIVE has been designed to satisfy unmet market needs. There have been over 4,500 Ti-ACTIVE devices successfully implanted to date."
MIDLINE II-Ti is based upon the STALIF MIDLINE II™ product family. MIDLINE II was designed to offer surgeons increased ease of use by reducing the surgical envelope required to implant the device while maintaining the superior biomechanics that have underpinned thirty years of STALIF surgical success. In harmony with Wolff's law, three strategically configured cancellous screws create additional compression at each treated segment. The Ti-ACTIVE coating increases the contact surface area and friction at the bony endplates. To date around 1,000 MIDLINE II devices have been implanted.
Gunwant Mallik, MD, Columbus, OH, states "The compressive fixation provided by the three lag screws, lordosis options and size options are very important. The titanium-coated PEEK option provides additional surface area that enhances stability." Additionally Jon White, MD, HOAG Orthopedic Institute, Irvine, CA commented "MIDLINE II represents the best ALIF device currently on the market due to the overall simplicity, dependability and comprehensive design rationale".
Centinel Spine also develops, manufactures, markets and sells the complete STALIF product family, which includes STALIF C®, STALIF C-TiTM for anterior cervical discectomy fusion (ACDF) procedures and STALIF LTM for lateral lumbar interbody fusion (LLIF) procedures. Recently, Centinel Spine received FDA clearance for ALTOS™ PCT, a Posterior Cervical Stabilization system specifically designed for use in either the cervical lateral masses or cervical-thoracic pedicles.
About Centinel Spine, Inc.
Centinel Spine, Inc. is a privately-held spinal device company leading the development and commercialization of the Stand-Alone, No-Profile, Integrated Interbody fusion technologies. For more information on Centinel Spine products and technologies, please visit the Company's web site at www.centinelspine.com.
The company began operations in August 2008, through the merger-acquisition of two pioneering medical device companies: Raymedica LLC and Surgicraft LTD. Today, Centinel Spine still embraces the pioneering culture developed at both originating companies and continues its corporate mission of becoming the leading anterior column support spine franchise, providing elegantly simple implants and instruments that are tissue-sparing and generate superior clinical outcomes.
Centinel Spine derived its name from the "Sentinel Sign" – the radiographic confirmation of a successful fusion anterior to the interbody device.
Source: Centinel Spine
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.